A Randomized Controlled Study on the Treatment of Helicobacter Pylori Infection with the New Combination of Traditional Chinese and Western Medicine
- Conditions
- Helicobacter pylori infection
- Registration Number
- ITMCTR2100004348
- Lead Sponsor
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) Diagnosed Helicobacter pylori infection through 13C urea breath test in the past month;
(2) Aged between 18-75 years, no gender limit;
(3) The patient voluntarily signed an informed consent form.
(1) Have used antibiotics or bismuth within 4 weeks before treatment, or used proton pump inhibitor or H2 receptor blocker within 2 weeks;
(2) Patients with serious diseases such as cardiovascular, cerebrovascular, liver, kidney, nerve and blood system, tumors, and mental diseases;
(3) Women who are pregnant or preparing to become pregnant, and women who are breastfeeding;
(4) People with allergies or a history of allergies to the drugs in the program;
(5) Patients who are participating in or have participated in other clinical trials within 1 month.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Helicobacter pylori eradication rate;
- Secondary Outcome Measures
Name Time Method TCM syndrome points;